ATLANTA, March 11 /PRNewswire/ --

- Leading Managed File Transfer and Job Scheduling Company focuses on future growth and special anniversary incentives for customers.

Stonebranch(R), Inc. (http://www.stonebranch.com/), the innovation leader in Managed File Transfer and Job Scheduling solutions, today announced its tenth anniversary celebration. As 2009 progresses, Stonebranch plans on honoring its milestone with special events, a new market direction and special anniversary offerings for its customers worldwide who have made its success possible.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090311/CL79789LOGO-a) (Logo: http://www.newscom.com/cgi-bin/prnh/20090311/CL79789LOGO-b)

LONDON, March 11 /PRNewswire/ --

Frost Sullivan's latest Strategic Analysis of the European Market for Electric Corner Modules finds that the global market size for ECMs will be around one million units by 2020. Suppliers, rather than vehicle manufacturers (VMs), will promote the market for ECMs. Design flexibility, weight reduction and fuel savings will be the main catalysts implementing ECMs.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO )

Enhanced design flexibility and additional space due to the absence of the transmission and engine will boost the adoption of ECMs, notes Frost Sullivan Industry Manager Vijayendra Rao. The implementation of ECM will also act as a product differentiator for OEMs to showcase their technological expertise.

LONDON, March 11 /PRNewswire/ --

Rocket XL, a Cossette agency, is bringing its market-leading social media and online influencer offering to London, and has hired Steve Forde, the creative force behind London's Channel 4 TV's agenda-setting social media campaigns for Skins and Lost, as Managing Director.

We believe the compelling point of difference in our offer is the depth and breadth of proven market leadership we have across our international offices, said Craig Howe, the founder and CEO of Rocket XL. Steve Forde is a brilliant talent who has delivered great results for Channel 4 and will fast-track our ability to deliver our full-service model in the UK.

HUNTINGTON BEACH, California, and AMSTERDAM, The Netherlands, March 11 /PRNewswire/ -- Agendia, a world leader in molecular cancer diagnostics, today announced that leading researchers from Agendia and the Netherlands Cancer Institute will present data from multiple studies at the 2009 St.Gallen Breast Cancer Conference. The St. Gallen Breast Cancer Conference, one of the premiere conferences in breast cancer research worldwide, takes place March 11th-14th, 2009 in St.Gallen, Switzerland.

The study results further underpin the predictive and prognostic power of Agendia's breast cancer recurrence test, MammaPrint(R) and will be discussed at the following poster sessions:

Thursday, 12 March 2009

Poster 0063

ARNHEM, The Netherlands, March 11 /PRNewswire/ --

- Favorable Market for Energy Consulting, Testing and Certification Activities

KEMA has realized continued growth in sales and results over 2008. Global developments in energy, like the transition to sustainable energy and a stronger international position, pushed net sales by 13.3% to EUR 226.7 million (2007: EUR 200.1 million). Autonomous sales growth increased to 15.2%, while net profit rose by 48.1% to EUR 16.6 million (2007: EUR 11.2 million) as a result of higher sales and continued improvement of operating processes. As in 2007, all business units contributed to this growth, which occurred in both the Dutch and the international offices.

Major developments in 2008

CALGARY, Canada, March 11 /PRNewswire/ --

- Deepwater Exploration Campaign Expected to Commence in the Fourth Quarter of 2009

Addax Petroleum Corporation (Addax Petroleum or the Corporation) (TSX:AXC and LSE:AXC), today announces that it has signed an agreement with a subsidiary of Transocean (Transocean) for the provision and operation of the Deepwater Pathfinder drillship to commence its deepwater exploration drilling campaign. Addax Petroleum expects to receive delivery of the Deepwater Pathfinder at the end of the third quarter 2009 and intends, subject to Joint Development Authority approval, to commence the drilling of the Kina prospect in Block 4 of the Joint Development Zone shortly thereafter.

CLEVELAND and ZURICH, Switzerland, March 11 /PRNewswire/ --

- Simbionix and VirtaMed Have Joined Forces to Provide OB/GYN Surgeons the Most Advanced Training System for Endoscopic Surgery

- The New VirtaMed HystSim(TM) Simulator Adds Hysteroscopy to Simbionix' Impressive Line of Medical Simulation and eLearning Products

Simbionix, the world's leading developer of medical simulation systems, and VirtaMed, a Swiss medical engineering company, announced today a global collaboration agreement. Simbionix will exclusively distribute, market, and provide service for the VirtaMed HystSim, an advanced virtual reality hysteroscopy simulator.

LONDON, March 11 /PRNewswire/ -- ThirdForce PLC, a provider of technology-enabled learning solutions and services has announced today that after a highly successful pilot project they have won the contract to become the exclusive supplier of Skills for Life provision to Whitbread PLC, the UK's largest hotel and restaurant group. Whitbread brands include: Premier Inn, Beefeater, Table Table, Brewers Fayre, Taybarns and Costa Coffee.

The successful contract win follows on from the astonishing results that were achieved in the pilot scheme at 16 sites. The pilot delivered unprecedented numbers of learners completing literacy and numeracy diagnostics and significant numbers completing the final National Skills for Life exam in a short period of time.

The immune response can protect us from basically any invader but it can also create disease - like it happens in autoimmunity where it attacks the own body - so to understand its regulation is an important tool to assure its proper functioning. In a Nature Immunology article, scientists in Portugal study one of the least understood white blood cells subsets – the gamma delta T cells – and reveal that it is composed by two distinct functional groups that can be identified according to the expression of a molecule called CD27, which is also determinant deciding which subset dominates the immune response.

TEL AVIV, Israel, March 11 /PRNewswire/ --

- The Value of the First Phase of the Project is More Than 150 Million Dollars

- Ofer Bloch, President CEO: This agreement, implemented during a global financial crisis, indicates that there is still an incentive to invest in mega agricultural projects using advanced technology